AbbVie Ventures Overview

  • Investor Type

  • Venture Capital

  • Status

  • Active

  • Professionals

  • 4

Professionals
  • Investments

  • 69

  • Portfolio

  • 22

  • Exits

  • 28

Exits

AbbVie Ventures General Information

Description

Founded in 2009, AbbVie Ventures is the corporate venture arm of AbbVie based in North Chicago, Illinois. The firm seeks to make minority investments in seed-stage, early-stage, and later-stage companies. The firm prefers to invest in therapeutics only in the areas of Oncology, Immunology, CNS, and Ophthalmology in the United States and Europe.

Contact Information

Formerly Known As
Abbott Biotech Ventures
Year Founded
2009
Investor Status
Actively Seeking New Investments
Trade Association
New England Venture Capital Association (NEVCA)
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
  • One North Waukegan Road
  • Building AP34-2
  • North Chicago, IL 60064
  • United States
+1 (847) 000-0000

AbbVie Ventures Investments (69)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Carisma Therapeutics 21-Sep-2022 PIPE 0000 Drug Discovery Generating Revenue 000000000 000000 00
00000000 000000000 01-Feb-2022 0000 00000 00.00 Drug Discovery Startup 0000000 000000 00.0
0000000 0000000000 05-Jan-2022 00000 00000 0000 Drug Discovery Generating Revenue 000000000 000000 00
0000000 0000000000 02-Nov-2021 00000 00000 0000 Drug Discovery Generating Revenue 000000000 000000 00
000000 00000000000 26-Oct-2021 00000 00000 0000 Biotechnology Pre-Clinical Trials
00000 000000000000 18-Aug-2021 00000 00000 0000 Drug Discovery Pre-Clinical Trials 0000000 0000000000 00.0
000000 00000000000 29-Jul-2021 0000 00000 00.000 Drug Discovery Stealth 0000 000000000
0000000 0000000000 15-Jul-2021 00000 00000 0000 Biotechnology Generating Revenue 0000000 0000000000 00.0
Ribon Therapeutics 14-Jul-2021 Later Stage VC 0000 Drug Discovery Clinical Trials - General
Caribou Biosciences 03-Mar-2021 Later Stage VC 00000 Biotechnology Generating Revenue/Not Profitable
You’re viewing 10 of 69 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AbbVie Ventures Exits (28)

Company Name Exit Date Exit Type Exit Size
Disc Medicine 30-Dec-2022 Reverse Merger 00000
0000000 0000000000 24-Mar-2022 000 00 00000000
00000000 000000000 26-Aug-2021 0000000 000000 00000
0000000 0000000000 23-Jul-2021 000 00000
0000000 01-Jun-2021 000000000 00000000
000000 00000000000 25-May-2021 000 00 00000000
0000 000000000000 16-May-2021 000000000000000000 000.00
000000 000000000 01-Apr-2021 000000000 00000000
Rodeo Therapeutics 30-Mar-2021 Merger/Acquisition 00000
Quench Bio 09-Mar-2021 Out of Business
You’re viewing 10 of 28 exits. Get the full list »

AbbVie Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

AbbVie Ventures Team (20)

Name Title Deals Funds Boards Office
Charles Kunsch Ph.D Managing Director 0 0 Cambridge, MA
John Gustofson Managing Director 0 0 Cambridge, MA
Margarita Chavez JD Managing Director 00 0 North Chicago, IL
Jasmina Marjanovic Ph.D Director 0 0 Cambridge, MA
Ana Dossantos Executive Redwood City, CA
You’re viewing 5 of 20 team members. Get the full list »

AbbVie Ventures Co-Investors (121)

Name With Exits Lead Partner Series Industry
Alexandria Venture Investments 4 0 0 Series chart Industry bar
RA Capital Management 0 0 0 Series chart Industry bar
Atlas Venture 0 0 0 Series chart Industry bar
Citadel Enterprise Americas 0 0 Series chart Industry bar
The Invus Group 0 0 Series chart Industry bar
You’re viewing 5 of 121 co-investors. Get the full list »